IMAS Announces Its Rebranding to ACCESS Forum.
"A great way to end the year, broadening the focus of our organization to be ACCESS writ large! This includes—most notably—bringing in the PATIENT, the ultimate arbiter as to whether "access" was achieved," says Joseph L. Boswell president of ACCESS Forum.
"The new name for the ACCESS Forum reflects the truly important purpose for this one-of-a-kind, global organization. There is no other organization with a singular focus on the pivotal role that market access, reimbursement, and evidence professionals around the world play every day in helping patients secure access to the therapies they need," says Chris Mancill, SVP & Head, Global Market Access, Pricing, and Value Demonstration at Bristol Myers Squibb, and Executive Board member of ACCESS Forum.
"The broader framing of this international organization to simply ACCESS reflects the breadth of the stakeholder ecosystem involved in ensuring patients have access to innovative health technologies. We are committed to bringing access stakeholders together to navigate the challenges of access today with an eye on tomorrow. In this environment we can share expertise across disciplines and focus on practical, hands-on approaches that bring the best of us together in heart and mind to support patients in this ever-changing and complex environment," says Eric Faulkner, Executive Board member of ACCESS Forum, and President, Chief Strategist of Passage Health Associates.
LINKS